Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Unity Biotechnology Inc (UBX)

Unity Biotechnology Inc (UBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates GlobeNewswire - Mon May 5, 2025

UBX : 0.2001 (-33.41%)
UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting GlobeNewswire - Thu May 1, 2025

UBX : 0.2001 (-33.41%)
UNITY Biotechnology Announces Publication in NEJM Evidence Highlighting the Potential of Senolytic Therapeutics to Provide Long-Term Improvements in Vision in DME GlobeNewswire - Wed Apr 23, 2025

UBX : 0.2001 (-33.41%)
UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates GlobeNewswire - Tue Apr 22, 2025

UBX : 0.2001 (-33.41%)
UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema GlobeNewswire - Mon Mar 24, 2025

UBX : 0.2001 (-33.41%)
UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025 GlobeNewswire - Sun Mar 23, 2025

UBX : 0.2001 (-33.41%)
UNITY Biotechnology Appoints Industry Leader and Ophthalmology Expert Yehia Hashad, M.D., to the Board of Directors GlobeNewswire - Mon Mar 10, 2025

UBX : 0.2001 (-33.41%)
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates GlobeNewswire - Fri Mar 7, 2025

UBX : 0.2001 (-33.41%)
UNITY Biotechnology Reports Granting of New Employment Inducement Award GlobeNewswire - Tue Jan 7, 2025

UBX : 0.2001 (-33.41%)
UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer GlobeNewswire - Mon Jan 6, 2025

UBX : 0.2001 (-33.41%)

Barchart Exclusives

This Dividend Stock Is Up 22% in a Month Despite Mixed Q2 Earnings. Don’t Sell Just Yet. Barchart - 44 minutes ago
Domino’s Pizza stock has rebounded sharply from its 2026 lows. While its valuation multiples have expanded and DPZ does not look as tempting now, dividend investors can stay put in the stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.